Comments on: GlaxoSmithKline Buys Sirtris for $720M

By: Skin

Skin — Sat, 24 Jan 2009 16:32:12 +0000

Would be interested see the updates on this thing, thanks.

By: razormd

razormd — Wed, 30 Apr 2008 03:22:45 +0000

…I absolutely agree that the deal is utter nonsense and probably some some GSK’s manager self-promoting idea to keep GSK at the “forefront” of science…the only things really accomplished were some venture capitalists no doubt cleaned up and the odds that we’ll all will be paying more for GSK drugs have increased substantially…what’s really disgusting is thinking about what 750 million dollars COULD have accomplished for healthcare in third world countries.

By: Elixir Hoping to Cash In On Sirtuins Too After GSK / Sirtris Deal — Pharmababble

Mon, 28 Apr 2008 14:51:22 +0000

[...] a patent for a class of SIRT2 regulators. I came down as pretty negative on the Sirtris deal in this post last week and nothing I’ve read by people presumably smarter than me has changed my mind. I [...]